Molecular Chain Elongation Mechanism for n ‐Caproate Biosynthesis by Megasphaera Hexanoica
Advanced Science · 2025
DOI: 10.1002/advs.202506069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Byoung Seung Jeon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Korea Institute of Ceramic Engineering and Technology, Osong, 28160, Republic of Korea. Hauptthemen laut MEDLINE: Megasphaera, Caproates. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation Center for Basic Metabolic Research, Korea Institute of Ceramic Engineering and Technology.
Abstract (Originalsprache)
The microbial production of medium‐chain carboxylates has attracted considerable interest owing to their potential applications in biofuels and specialty chemicals; however, the underlying biosynthetic mechanisms remain incompletely understood. The present study evaluates the medium‐chain carboxylate‐producing microbe Megaspahera hexanoica using genomic analysis, transcriptome analysis, and metabolic engineering. Additionally, the n ‐caproate synthesis pathway of M. hexanoica is characterized with fructose as an electron donor, and the substrate specificity of the respective proteins is evaluated by constructing an n ‐caproate biosynthetic pathway in Escherichia coli . Among all r‐BOX or RBO genes, thl _1583, which encodes β‐ketothiolase ( Mh THL), is identified as the most critical enzyme for the carbon chain elongation mechanism in M. hexanoica . Therefore, Mh THL is compared with other well‐studied β‐ketothiolases ( Ck THL from Clostridium kluyveri, Re BktB from Ralstonia eutropha ( Cupriavidus necator ), Ec AtoB from E. coli , and Ca THL from C. acetobutylicum ). Mh THL is found to exhibit the highest n ‐caproate production, as evidenced by the protein crystal structure of Mh THL. Structural comparisons with other thiolases show that Mh THL has a larger substrate‐binding pocket than Re BktB. Thiolase mutants generated by site‐directed mutagenesis reveal that two residues (Leu87 and Val351) are essential for determining the size of the substrate‐binding pocket.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Korea Institute of Ceramic Engineering and Technology, Osong, 28160, Republic of Korea.
- Department of Chemical Engineering, Hanyang University, Seoul, 04763, Republic of Korea.
- School of Life Sciences, KNU Creative BioResearch Group, KNU Institute for Microorganisms, Kyungpook National University, Daegu, 41566, Republic of Korea.
- Viral Disease Division, Animal and Plant Quarantine Agency, 177, Hyeoksin 8-ro, Gimcheon-si, Gyeongbuk, 39660, Republic of Korea.
- Department of Biological and Chemical Engineering, Aarhus University, Gustav Wieds vej 10D, Aarhus C, 8000, Denmark.
- Environmental Biotechnology Group, Department of Geosciences, University of Tübingen, Schnarrenbergstraße 94-96, 72076, Tübingen, Germany.
ORCID-Profile: Byoung-In Sang
Förderung
- Novo Nordisk Foundation Center for Basic Metabolic Research
- Korea Institute of Ceramic Engineering and Technology
Zitieren
APA
Jeon, B. S., Kim, E. J., Seo, H., Kim, H., Shin, S., Schlaiß, C., Angenent, L. T., Kim, K. J., & Sang, B. I. (2025). Molecular Chain Elongation Mechanism for n ‐Caproate Biosynthesis by Megasphaera Hexanoica. Advanced Science. https://doi.org/10.1002/advs.202506069
Vancouver
Jeon BS, Kim EJ, Seo H, Kim H, Shin S, Schlaiß C, et al. Molecular Chain Elongation Mechanism for n ‐Caproate Biosynthesis by Megasphaera Hexanoica. Advanced Science. 2025. doi:10.1002/advs.202506069
BibTeX
@article{Jeon2025,
author = {Jeon, Byoung Seung and Kim, Eun-Jung and Seo, Hogyun and Kim, Hyunjin and Shin, Seungjin and Schlaiß, Caroline and Angenent, Largus T and Kim, Kyung-Jin and Sang, Byoung-In},
title = {Molecular Chain Elongation Mechanism for n ‐Caproate Biosynthesis by Megasphaera Hexanoica},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202506069}
}
EUVIMED